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Background: Opportunistic Infections (OIs) constitute the first manifestation of HIV infection, indicating significant 
immunodeficiency. OIs remain a leading cause of morbidity and mortality in HIV-infected persons. Since most of OIs 
are readily treatable and preventable, every effort should be made to facilitated their management. However, there 
is a need to establish local prevalence of OIs and evaluate their management. This would guide in prioritizing resource 
and support development of suitable management strategies.   
Objective: The main objective of this study was to establish the prevalence of HIV-related OIs in adult patients.  
Methodology: A hospital-based cross-sectional study conducted between July and August 2011 at Kenyatta National 
Hospital –Comprehensive Care Center (KNH-CCC). Adult patients who were HIV positive and attending outpatient 
clinic at KNH-CCC were included. Information was collected on patients’ demographics, clinical characteristics and 
presence of new or active OIs. Data was analyzed using Statistical Package for social Sciences (SPSS) version 11.5. 
Results: The prevalence of opportunistic infections was 14.1 % (95% CI: 10.7-18.5).  Overall, the most commonly 
reported bacterial infection was pneumonia (6.4%) whereas pulmonary tuberculosis was reported in 3.6% of 
patients. Significant association was found between a patients’ current OI status and WHO stage when HIV was 
diagnosed (AOR= 3.79 [95% CI = 1.43 – 10.03], P=0.007) and duration since HIV diagnosis (AOR 3.89 [95% CI= 1.58-
9.59], P=0.003.  90% of patients were prescribed Co-trimoxazole as chemoprophylaxis agent. 
Conclusion: There was a high prevalence of OIs among the HIV/AIDS patients at KNH-CCC. Bacterial Pneumonia and 
pulmonary tuberculosis were the most commonly observed OIs. 
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1. Introduction 
Opportunistic infections (OIs) have been defined as 
infections that are more frequent, or more severe 
because of immunosuppression, were the main cause of 
morbidity and mortality in people living with HIV and 
AIDS (Walensky et al, 2006). However, the widespread 
uses of Highly Antiretroviral Therapy (HAART) and 
Chemoprophylaxis have had the most profound 
influence on reducing OI-related mortality (Walensky et 
al, 2006; Palella et al, 1998). 
A review of incidence of HIV-related OIs between 1996 
and 1998 in the United States, reported decreases in the 
incidence of Pneumocystis carinii pneumonia (PCP), 
esophageal candidiasis, and disseminated 
Mycobacterium avium complex (MAC) disease were 
more pronounced in 1995-1998, during which time 
highly active antiretroviral therapy ( HAART) was 
introduced into medical care (Kaplan et al, 2000).  
In Kuala Lumpur hospital, a retrospective review of 419 
HIV/AIDS patients record showed that the prevalence of 
African Journal of Pharmacology and Therapeutics Vol. 5 No. 3 Pages 163-168, 2016 
Open Access to full text available at  http://journals.uonbi.ac.ke/ajpt      
 
Research Article 
 Malwal et al, Afr. J. Pharmacol. Ther. 2016. 5(3): 163-168 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
164 
four major OIs were 48%, 13 %, 11% and 7 % for 
Tuberculosis, PCP, toxoplasmosis and cryptococcal 
meningitis respectively (Nissapatorn et al, 2003). 
Furthermore , the Indian study reported that parasitic 
infection were found  in 35 % HIV infected patients and 
low CD4 count was significantly associated with OIs 
(Kulkarni et al, 2009).   
A cross- sectional study that was carried out in HIV-
infected children at KNH-CCC estimated the prevalence 
of OIs to be 14.3 %. In addition, another cross –sectional 
study was carried out in Taita Tavet and Murang’a 
districts of Kenya, reported OIs prevalence of 3.3% and 
4.1 % respectively (Mbatia, 2011). However, these few 
studies on the prevalence of OIs in Kenya have made it 
difficult to implement clinical strategies and program to 
prevent OIs consequences and decrease it cost of 
management. OIs consume a large share of healthcare 
budget and significantly impair HIV/AIDs patient’s 
quality of life. Thus there is great interest in identifying 
and then remedying, predisposing factors that increase 
the risk of OIs. 
2. Methodology 
2.1 Study design 
A hospital based cross-sectional review of HIV-infected 
adult patent’s files to establish the prevalence and 
management of HIV/AIDS related opportunistic 
infections. 
2.2 Study site  
The present study was carried out at the Kenyatta 
National Hospital- comprehensive care center (KNH-
CCC) between July and Aug 2011. KNH is the largest 
teaching and referral hospital in East Africa. 
Comprehensive Care Center  is an out patients clinic that 
serves as primary care  and  public referral center for 
HIV/AIDS patients from all over Kenya.  
Files were included in the study if the patients were HIV 
positive evidence by confirmatory result, adult defined 
by age of 18 years and above and attending outpatient 
clinic at KNH-CCC.  Incomplete patient files (with missing 
pages) or files of patients previously included or files of 
patient with history of HIV exposure  and tested HIV 
negative  result  were excluded from the study. 
2.3 Study population  
A total of 333 patient files were reviewed out of 1239 
patients.  311 files were included in analysis and 22 files 
were eliminated form study because of failure to meet 
the inclusion criteria. 
2.3 Sampling  
Sample size for this study was calculated on the basis of 
the prevalence of 15%, at precision of 5 % and a 95 % 
level of confidence. The Fischer formula for determining 
the minimum sample size was used. 
The files of patients seen by clinicians during the study 
period were obtained. The files were selected by simple 
random sampling and those meeting the inclusion 
criteria were reviewed for records of current 
opportunistic infections. The files were reviewed for any 
active or new OI recorded on that day of visit.  OIs 
occurring on the previous visits and not active were not 
considered.  
2.4 Data collection  
The independent variable include patients’ demographic 
characteristic such as age and sex. 
The primary outcome of interest was proportion of HIV 
+ve adult patient who developed any of the following 
OIs: Bacterial infections (e.g. pulmonary tuberculosis, 
extraplumonary tuberculosis, bacterial pneumonia 
mycobacterium avium complex); fungal infections (e.g. 
oral candidiasis, esophageal candidiasis, Pneumocystis 
jiroveci pneumonia, cryptococcal neuralagia, 
hisotoplasmosis); viral infections (herpes infection, 
Hepatitis B virus, Hepatitis C virus infection, 
cytomegalovirus infections); related parasitic infections 
(e.g. cryptosporidiosis, toxoplasmic encephalitis); and 
related malignancy (e.g. Kaposi sarcoma, Non-Hodgkin’s 
lymphoma). 
The secondary outcome of interest were factors 
associated with OIs; these included CD4 counts, viral load, 
World Health Organization stage of HIV, duration on 
HAART, clinical treatment failure and patient’s social 
behavior such as alcohol , smoking and drug abuse and 
current opportunistic infection and their management. 
2.5 Statistical analysis 
Data were coded and entered into predesigned Microsoft 
Office Access 2003 and analyzed using Statistical 
Package for social Sciences (SPSS) version 11.5.  
Descriptive statistics were computed to summarize the 
participant’s social-demographic, medical history, 
factors predisposing HIV infected patients to develop 
OIs, current opportunistic infections and opportunistic 
infections management with regard to Kenya National 
guidelines.  Categorical variables were summarized 
using frequency (%), while continuous variables were 
summarized using means.  
Data were reported as mean +/- SD for continuous data, 
frequency (percentage) for categorical. The correlation 
between current opportunistic infections status and 
selected demographic characteristics and current OIs 
and patient medical history were assessed using logistic 
regression and all variables demonstrating an 
association at P < 0.1 during bivariate analysis were 
candidate for inclusion in multivariate analysis. Binary 
logistic regression ‘backward conditional’ method was 
used with removal at P < 0.05.  
2.6 Ethical consideration 
Institution approval to carry out the study was obtained 
from the Kenyatta National Hospital/University of 
Nairobi - Ethics and Research Committee (KNH/UON-
ERC Ref No.: KNH-ERC/A/161). The review of patient 
files was done within KNH-CCC premises and data 
obtained was kept under lock and key or in pass worded 
computer. Data forms did not bear patients’ name or 
clinic numbers’. Patients were only identified by study 
numbers. 
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3.  Results  
From 15th July to 15th August 2011, a total of 311 files 
were reviewed for active Opportunistic infections 
present at the index visit.  Demographic characteristics 
of the patients are summarized in Table 1. At the 
enrolment, the mean age of the patients was 41 ± (9SD) 
with rage of 21 and 74 years.  The majority of 
participants 192 (58.8%) were female. 
Table 1: Demographic characteristic of the study 
Participants 
Variable  N=311 % 
Age in years 
18-24  
25-34 
35-44 
45-55 
> 55 
Sex  
Male  
Female  
Marital status  
Single  
Married  
Divorced/Widowed  
Education level 
</= Secondary  
 >Secondary  
No response  
Occupation 
Unemployed  
Employed 
No response   
 
6 
76 
133 
75 
21 
 
128 
183 
 
73 
196 
42 
 
220 
57 
34 
 
81 
202 
28 
1.9 
24.4 
42.8 
24.1 
6.8 
 
41.2 
58.8 
 
23.5 
63.0 
13.5 
 
79.4 
20.6 
 
 
28.6 
71.4 
 
Assessment of patient’s medical records reveals that 
55.3% of patients had their HIV diagnosis more than 36 
months prior to the study time (Table 2). After HIV 
diagnosis confirmation, approximately 84.2 % of 
patients initiated HAART instantly.  At the beginning of 
therapy, 43.5% had CD4 cell count ≤ 200 cell/mm3. A 
high proportion of patients (35.1%) initiated HAART at 
WHO stage III with smaller proportioned (16.8%) being 
initiated at stage IV. 
17.4% of patients had at least one of the three factors 
commonly associated with OIs. Figure 1 shows 
distribution of participants by factors known to 
predispose HIV infected patients to OIs. 
An analysis of current OIs showed that 4 participants 
(1.3%) had 2 types of infections while others 40 (12.9%) 
had only 1 type. This gave an overall prevalence of OIs of 
14.1 % (95% CI: 10.7-18.75).  The prevalence of current 
OIs was 20 % among patients taking Stavudine based 
regimen.  90% of patients were on Co-trimoxazole 
prophylaxis. 
Table 2: Clinical characteristics of study participants 
Variables N=311 % 
Duration since diagnosis in months   
0 - 12 months 64 20.6 
13 - 24 months 37 11.9 
25 - 36 months 38 12.2 
>36 months 172 55.3 
HAART started   
Yes 262 84.2 
No 49 15.8 
CD4 count (cells/mm3) when HAART started  
</= 200 131 43.5 
>200 170 56.5 
No response 10  
WHO stage when HIV was diagnosis  
I 73 25.6 
II 64 22.5 
III 100 35.1 
IV 48 16.8 
No response 26  
Duration being on HAART (Months)   
0 - 12 Months 47 15.1 
13 - 24 Months 38 12.2 
25 - 48 Months 70 22.5 
>48 months 109 35.0 
Not on HAART 47 15.1 
Current HAART regimen base   
AZT based regimen 83 26.7 
D4T based regimen 15 4.8 
TDF based regimen 161 51.8 
Other regimen 4 1.3 
Not on HAART 48 15.4 
Current WHO stage   
I 218 81.0 
II 12 4.5 
III 32 11.9 
IV 7 2.6 
No response 42  
Current CD4 count (cells/mm3)   
</= 200 54 21.8 
>200 194 78.2 
No response 63  
 
Opportunistic infections management compared to the 
Kenya National Manual for the management of HIV-
related OIs and other condition.  Over 29% of the OIs 
were managed according to the Kenya National 
guideline.  
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Figure 1: Distribution of patient by factors known to 
predispose HIV infected adult to develop OIs. 
A review of patients’ Current OIs was analyzed as 
presented in Table 3. The most commonly reported 
bacterial infection was pneumonia (6.4%), whereas 
pulmonary tuberculosis by 3.6 % of the participants. 
Among fungal infections, oral candidiasis (0.6%) and 
fungal skin infection (0.6 %) had the highest frequency 
of occurrence as reported by the participants. 
Table 3: Current opportunistic infections 
Variable  N= 311 % 
Related bacterial infections 
Pulmonary TB 
Pneumonia bacterial  
None  
Related fungal infections 
Oral Candidiasis 
Esophageal Candidiasis 
Pneumocystic jiroveci Pneumonia 
Fungal skin Infection  
None  
Related Viral Infection  
Herpes infection ( HSV and HZV) 
Hepatitis C virus infection 
None  
Related parasitic infection 
Worms 
None  
Related Malignancy  
Kaposi sarcoma  
Invasive carcinoma, cervix 
None  
Other opportunistic infection 
Wasting syndrome 
Diarrhea  
None  
 
12 
20 
280 
 
2 
1 
1 
2 
305 
 
2 
1 
308 
 
1 
310 
 
2 
1 
308 
 
1 
3 
307 
3.6 
6.4 
90.0 
 
0.6 
0.3 
0.3 
0.6 
98.1 
 
0.6 
0.3 
99.0 
 
0.3 
99.7 
 
0.6 
0.3 
99.0 
 
0.3 
1.0 
98.7 
 
Multivariable regression was performed to identify 
independent predictor(s) of current state of 
opportunistic infection among adult patients diagnosed 
with HIV. Four factors associated with current 
opportunistic infections status at P<0.1 during bivariate 
analysis were considered for multivariate analysis. 
These include; (1) Duration since HIV diagnosis 
(months), (2) WHO clinical stage of disease when HIV 
was diagnosed, (3) Duration being on HAART (months) 
and (4) Current CD4 count. After fitting all the four 
factors together, variance of opportunistic infection due 
to duration being on HAART (months) and current WHO 
clinical stage was less than the variance of opportunistic 
infection due to duration since HIV diagnosis (months) 
and WHO clinical stage when HIV was diagnosed, there 
by rendering the two factors (Duration being on HAART 
(months) and Current WHO disease stage) statistically 
insignificant and therefore removing them from the 
model.  Duration since HIV diagnosis (months) and WHO 
clinical stage when HIV was diagnosed were therefore 
retained in the final model.  
Adjusting for duration since HIV diagnosis (months), 
WHO clinical staging of disease III or IV was significantly 
associated with current opportunistic infection (AOR= 
3.79 [95% CI = 1.43 – 10.03], P=0.007). A patient in stage 
III or IV when HIV was diagnosed has 3.79-folds risk of 
having opportunistic infection compared to one in stage 
I.  
Similarly, adjusting for WHO clinical stage of disease 
when HIV was diagnosed, less than or equal to 12 months 
duration since diagnosis was significantly associated 
with current opportunistic infection (AOR= 3.89 [95% CI 
= 1.58 – 9.59], P=0.003). A patient with less than or equal 
to 12 months duration since HIV diagnosis has 3.89-folds 
risk of having opportunistic infection compared to one 
with more than 36 months. 
4. Discussion 
The present study was designed to establish the 
prevalence of OIs in HIV infected patient at Kenyatta 
National Hospital- Comprehensive care Center. The 
prevalence of OIs was found to be 14.1% (95% CI: 10.7-
18.5). Our finding is almost similar to the cross-sectional 
study carried out in children infected with HIV at KNH 
which estimated the prevalence of OIs in children to be 
14.3 % (Mutua, 2008). However, it expected that there 
should be a reduction in OIs prevalence among HIV-
infected adults following initiation of antiretroviral 
therapy and chemoprophylaxis (Detels et al, 2001; 
Kaplan et al, 2000; Mocroft et al, 2003). 
The finding of this study is higher than the findings of 
cross-sectional study that was carried out in Murang’a 
and Taita Taveta, which estimated the prevalence of OIs 
to be 4.1% and 3.3% respectively (Mbatia, 2011). This 
difference may be attributed to geographical and 
population density variation between Nairobi, Murang’a 
and Taita Taveta. Or because: KNH being a referral 
hospital may have received more seriously ill patients 
than the district hospital. 
Bacterial pneumonia was the most frequent 
opportunistic infection (6.4%). However, retrospective 
review of cohort of HIV infected patients in Lebanon 
showed that cerebral toxoplasmosis is the most frequent 
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OI reported by 21%, followed by fungal infections with 
17% (Gebo et al, 2005). 
Our data showed that pulmonary tuberculosis and 
diarrhea were the second leading OIs with a prevalence 
of 3.6% and 1.0% respectively. This finding is contrary to 
the finding of Kuala Lumpur hospital based study that 
estimated prevalence of tuberculosis to be 48% (Kaplan 
et al, 2000). However, Kuala Lumpur hospital based 
study was a retrospective of HIV-infected cohort from 
1994 to 2011.  
In South Africa, one out of six patients (16%) who had no 
symptoms of tuberculosis at the time of diagnosis 
screening actually had positive sputum culture for TB 
(Wood et al, 2007). Even adding chest X-ray, clinician 
may still miss many cases (Greenberg et al, 1994).  
Furthermore, tuberculosis diagnosis requires several 
days before definite and objective diagnosis is 
confirmed. Therefore, there is possibility that some 
tuberculosis cases may have been missed during the 
study period or referred to TB clinic. However, our 
finding is more than 3 folds the finding of WHO Global 
surveillance and monitoring project which reported the 
rate of TB-HIV co- infection exceed 1 per 100 population 
in some areas in Sub-Saharan Africa (WHO, 2011). 
Kaposi sarcoma (KS) was among the commonly reported 
OIs by 0.6% of patients. However, observation cohort of 
HIV–infected adult with AIDS associated KS in South 
Africa estimated the prevalence of KS to be 3.6% (Chu et 
al, 2010). This difference may explained by the variation 
of   study design. 
The study found that there was significant association 
between study population’s current OIs and WHO stage 
when HIV was diagnosed (P=0.007). There was high 
proportion of OI among participants    in WHO stage III 
or IV of the disease (20.3%) compared to those in stage 
I(9 .6%). The proportion of OI among participants in 
stage II (6.3%) is less than those in stage I. A patients in 
stage III or IV was 3.7 [95% CI: 1.43-10.03] times more 
likely to develop OI compared to one in stage I. 
These findings support the fact that majorities of 
patients are unaware of their HIV infection and seek 
medical care when OIs become initial indictor of their 
disease (Jones et al, 1999; Perbost et al, 2005; Croda et 
al, 2006). Hence a lot of efforts are needed to enhance 
and encourage early detection of asymptomatic HIV-
infected patients and providing them with timely 
antiretroviral therapy and appropriate 
chemoprophylaxis against specific OIs,  would decrease 
morbidity, mortality and improve the quality of life of 
HIV-infected patients in the country. 
Similarly, adjusting for WHO clinical stage when HIV was 
diagnosed, less than or equal to 12 months duration 
since HIV diagnosis was significantly associated with 
current OI (AOR = 3.89 [95% CI: 1.58-9.59], P= 0.003).  
Out 0f the 44 patients with at least one opportunistic 
infection, 29.5% were not managed according to the 
Kenya National Manual for the Management of HIV-
related OIs and other conditions. OIs have been the 
principle cause of morbidity and mortality in people 
living with HIV and AIDS (Walensky et al, 2006). 
However, in the early 1990’s, the use of HAART, 
chemoprophylaxis and better strategy for management 
of OIs contributed to improve quality of life and survival 
by reducing OIs related mortality (Palella et al, 1998; 
Walensky et al, 2006). Hence a lot of effort is needed to 
reinforce adherence of health care providers to National 
Manual for management of HIV-related OIs and other 
conditions, which is the better strategy to improve 
quality of life and survival. 
5. Conclusion 
The overall prevalence of opportunistic infections was 
14.1%. Bacterial Pneumonia and pulmonary 
tuberculosis were the most commonly observed 
opportunistic infections during the study period. Co-
trimoxazole chemoprophylaxis was used by more than 
90% of the patients, indicating a high adherence by the 
health workers to the national OIs prophylaxis 
recommendations. However, more than 29% of 
opportunistic infections were not managed according to 
the Kenya National Manual for the management of OIs 
and related Conditions. 
These findings support the recent WHO 
recommendations to start ART earlier before profound 
immune destruction occurs. Adherence of health care 
providers to Kenya National Guideline in management of 
OIs should be reinforced. 
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